中国医药健康产业股份有限公司2025年半年度报告摘要

Group 1 - The company plans to distribute a cash dividend of 0.1966 yuan per 10 shares, totaling approximately 29.41 million yuan, based on a total share capital of 1,495,879,748 shares as of June 30, 2025 [1][35][36] - The company will not implement a capital reserve transfer to increase share capital for the first half of 2025 [1][36] - The board of directors and the supervisory board have confirmed the authenticity, accuracy, and completeness of the half-year report [3][20] Group 2 - The board meeting held on August 27, 2025, approved the half-year report and the profit distribution plan [8][39] - The supervisory board also reviewed and approved the half-year report and the profit distribution plan, confirming compliance with legal and regulatory requirements [25][29] - The company has ensured that the profit distribution plan considers profit realization, cash flow status, and funding needs [39][41]